The company is working alongside its Indian JV, CoSara Diagnostics, to support faster international deployment if the outbreak spreads globally. ・The program includes both Bundibugyo-specific and ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Product Revenue -- $0.4 million, decreased from $0.8 million, reflecting limited commercial activity and ongoing investment ...

Co-Diagnostics, Inc. CODX stock is trading higher on Wednesday as the company announced a private placement aimed at raising ...

Investors might want to bet on Co-Diagnostics, Inc. (CODX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

The molecular diagnostics firm revealed it has signed a Memorandum of Understanding with a Saudi Arabian partner to potentially create a joint venture aimed at developing and distributing its Co-Dx™ ...

Detailed price information for Co-Diagnostics Inc (CODX-Q) from The Globe and Mail including charting and trades.